Humana
Stock Forecast, Prediction & Price Target
Humana (HUM) stock Price Target by analysts
Humana (HUM) stock Price Target by analysts
Average Price Target
$275.75
Potential downside: -4.51%
Humana price prediction
What is Humana stock analysts` prediction?
Humana stock forecast: Based on 6 Wall Street analysts` predicted price targets for Humana in the last 3 months, the avarage price target is $275.75, with a high forecast of $NaN. The average price target represents a -4.51% change from the last price of $288.8.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Humana stock Price Target by analysts
Full breakdown of analysts given Humana price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
George Hill Deutsche Bank | 0% 0/2 | 9 months ago | $248 -14.12% downside | $287.65 | StreetInsider | Previous targets (1) |
George Hill Deutsche Bank | 0% 0/2 | 11 months ago | $250 -13.43% downside | $260.57 | StreetInsider | Previous targets (1) |
Andrew Mok Barclays | 33.33% 1/3 | 11 months ago | $250 -13.43% downside | $245.45 | TheFly | Previous targets (2) |
Ben Hendrix RBC Capital | 0% 0/1 | 11 months ago | $265 -8.24% downside | $236.29 | TheFly | Previous targets (0) |
David Windley Jefferies | 0% 0/2 | 11 months ago | $253 -12.39% downside | $240.03 | TheFly | Previous targets (1) |
Jessica Tassan Piper Sandler | 0% 0/2 | 11 months ago | $274 -5.12% downside | $239.32 | TheFly | Previous targets (1) |
Kevin Fischbeck Bank of America Securities | 50% 1/2 | 12 months ago | $247 -14.47% downside | $246.49 | TheFly | Previous targets (1) |
David Windley Jefferies | 0% 0/2 | 12 months ago | $419 45.08% upside | $319.57 | StreetInsider | Previous targets (1) |
Frank Morgan RBC Capital | 0% 0/2 | about 1 year ago | $400 38.50% upside | $364.06 | StreetInsider | Previous targets (1) |
Michael Wiederhorn Oppenheimer | 33.33% 1/3 | about 1 year ago | $400 38.50% upside | $361.61 | TheFly | Previous targets (2) |
David MacDonald Truist Financial | 66.67% 2/3 | about 1 year ago | $400 38.50% upside | $382.22 | TheFly | Previous targets (2) |
Jessica Tassan Piper Sandler | 0% 0/2 | about 1 year ago | $392 35.73% upside | $355.8 | TheFly | Previous targets (1) |
Andrew Mok Barclays | 33.33% 1/3 | about 1 year ago | $370 28.11% upside | $349.55 | TheFly | Previous targets (2) |
Michael Wiederhorn Oppenheimer | 33.33% 1/3 | over 1 year ago | $370 28.11% upside | $315.98 | TheFly | Previous targets (2) |
Sarah James Cantor Fitzgerald | 0% 0/1 | over 1 year ago | $360 24.65% upside | $315.98 | StreetInsider | Previous targets (0) |
Frank Morgan RBC Capital | 0% 0/2 | over 1 year ago | $353 22.22% upside | $315.98 | StreetInsider | Previous targets (1) |
Andrew Mok Barclays | 33.33% 1/3 | over 1 year ago | $310 7.34% upside | $351.45 | TheFly | Previous targets (2) |
Unknown Truist Financial | N/A | over 2 years ago | $560 93.90% upside | $474.1 | Benzinga | N/A |
Unknown Cowen & Co. | N/A | over 2 years ago | $581 101.17% upside | $484.71 | Benzinga | N/A |
Unknown Credit Suisse | N/A | over 2 years ago | $575 99.09% upside | $476.57 | Benzinga | N/A |
Unknown UBS | N/A | over 2 years ago | $620 114.68% upside | $486.03 | Benzinga | N/A |
Unknown J.P. Morgan | N/A | over 2 years ago | $625 116.41% upside | $492.54 | Benzinga | N/A |
Nathan Rich Goldman Sachs | 50% 1/2 | over 2 years ago | $652 125.76% upside | $528.9 | StreetInsider | Previous targets (1) |
Unknown Mizuho Securities | N/A | almost 3 years ago | $615 112.95% upside | $558.3 | Benzinga | N/A |
Unknown RBC Capital | N/A | almost 3 years ago | $544 88.36% upside | $505.88 | Benzinga | N/A |
Unknown Oppenheimer | N/A | almost 3 years ago | $550 90.44% upside | $491.49 | Benzinga | N/A |
Unknown Truist Financial | N/A | almost 3 years ago | $570 97.36% upside | $493.38 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $494 71.05% upside | $474.44 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $540 86.98% upside | $478.35 | Benzinga | N/A |
David MacDonald Truist Financial | 66.67% 2/3 | about 3 years ago | $550 90.44% upside | $491.79 | Pulse 2.0 | Previous targets (2) |
Unknown Truist Financial | N/A | about 3 years ago | $550 90.44% upside | $473.56 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $514 77.97% upside | $443.01 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $541 87.32% upside | $442.3 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $512 77.28% upside | $457.31 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 3 years ago | $535 85.24% upside | $443.37 | Benzinga | N/A |
Kevin Caliendo UBS | 50% 1/2 | over 3 years ago | $520 80.05% upside | $453.97 | Pulse 2.0 | Previous targets (1) |
David MacDonald Truist Financial | 66.67% 2/3 | over 3 years ago | $490 69.66% upside | $451.33 | Pulse 2.0 | Previous targets (2) |
Steven Valiquette Barclays | 100% 1/1 | over 3 years ago | $490 69.66% upside | $362.52 | TheFly | Previous targets (0) |
Kevin Caliendo UBS | 50% 1/2 | over 3 years ago | $486 68.28% upside | $362.52 | MarketWatch | Previous targets (1) |
Nathan Rich Goldman Sachs | 50% 1/2 | over 3 years ago | $472 63.43% upside | $460.34 | TheFly | Previous targets (1) |
A.J. Rice Credit Suisse | 100% 1/1 | almost 4 years ago | $513 77.63% upside | $452.06 | TheFly | Previous targets (0) |
Kevin Fischbeck Bank of America Securities | 50% 1/2 | almost 4 years ago | $530 83.51% upside | $452.06 | TheFly | Previous targets (1) |
Michael Wiederhorn Oppenheimer | 33.33% 1/3 | almost 4 years ago | $510 76.59% upside | $452.06 | StreetInsider | Previous targets (2) |
Steven Halper Cantor Fitzgerald | 100% 1/1 | almost 4 years ago | $480 66.20% upside | $457.94 | StreetInsider | Previous targets (0) |
Gary Taylor Cowen & Co. | 100% 1/1 | about 4 years ago | $479 65.85% upside | $415.01 | TheFly | Previous targets (0) |
Michael Newshel Evercore ISI | 100% 1/1 | about 4 years ago | $450 55.81% upside | $424.06 | TipRanks | Previous targets (0) |
Scott Fidel Stephens | 100% 1/1 | about 4 years ago | $500 73.13% upside | $423.34 | TheFly | Previous targets (0) |
Lisa Gill J.P. Morgan | 100% 1/1 | about 4 years ago | $514 77.97% upside | $453.35 | TheFly | Previous targets (0) |
Justin Lake Wolfe Research | 100% 1/1 | over 4 years ago | $498 72.43% upside | $443.19 | StreetInsider | Previous targets (0) |
Humana Financial Estimates
Humana Revenue Estimates
Humana EBITDA Estimates
Humana Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $83.06B N/A | $92.87B 11.80% | $106.37B 14.54% | Avg: $115.26B Low: $112.86B High: $117.10B avg. 8.35% | Avg: $121.73B Low: $119.17B High: $124.43B avg. 5.61% | Avg: $135.03B Low: $132.20B High: $138.03B avg. 10.93% | |
Net Income
% change YoY
| $2.93B N/A | $2.80B -4.33% | $2.48B -11.29% | Avg: $2.32B Low: $1.80B High: $3.00B avg. -6.74% | Avg: $2.84B Low: $2.52B High: $3.59B avg. 22.62% | Avg: $4.29B Low: $4.17B High: $4.41B avg. 50.82% | |
EBITDA
% change YoY
| $4.13B N/A | $4.81B 16.53% | $4.93B 2.40% | Avg: $6.35B Low: $6.22B High: $6.45B avg. 28.89% | Avg: $6.71B Low: $6.57B High: $6.86B avg. 5.61% | Avg: $7.44B Low: $7.28B High: $7.61B avg. 10.93% | |
EPS
% change YoY
| $22.79 N/A | $22.2 -2.58% | $20.09 -9.50% | Avg: $19.64 Low: $14.48 High: $24.15 avg. -2.25% | Avg: $24.77 Low: $20.29 High: $28.86 avg. 26.12% | Avg: $34.5 Low: $33.56 High: $35.49 avg. 39.29% | |
Operating Expenses
% change YoY
| $-79.64B N/A | $89.07B 211.83% | $102.36B 14.92% | Avg: $14.19B Low: $13.90B High: $14.42B avg. -86.13% | Avg: $14.99B Low: $14.67B High: $15.32B avg. 5.61% | Avg: $16.63B Low: $16.28B High: $17.00B avg. 10.93% | |
FAQ
What is Humana stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.23% in 2025-2027.
We have gathered data from 17 analysts. Their low estimate is 1.80B, average is 2.32B and high is 3.00B.
What is Humana stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 8.29% in 2025-2027.
We have gathered data from 15 analysts. Their low revenue estimate is $112.86B, average is $115.26B and high is $117.10B.
What is Humana stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.05% in 2025-2027.
We have gathered data from 17 analysts. Their low earnings per share estimate is $14.48, average is $19.64 and high is $24.15.
What is the best performing analyst?
In the last twelve months 6 analysts have been covering Humana stock. The most successful analyst is George Hill.